Oncode Institute and ArgoBio launch Laigo Bio

Written By Guest User

Laigo Bio is a targeted protein degradation biotech with programs in oncology and neurological disorders

Utrecht, Paris-Ferbuary 2022 - ArgoBio and Oncode Institute have teamed up with Oncode Investigator Madelon Maurice, researcher and group leader at UMC Utrecht, to launch Laigo Bio, a new company in the emerging field of target protein degradation. The company has additionally secured funding from Oncode Bridge.

 Exciting Launch of Laigo Bio, a new company started by Center of Molecular PI Madelon Maurice and collaborators. Congratulations to all involved and good luck, especially to Maureen Spit.

Guest User
Previous

Hugo Snippert receives ZonMw Vidi grant
Next

Associate Professors